| Jun 07 | Jun 06 | Jun 05 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | |||
| Gross Profit | - | - | - |
| Operating Income | $ -128.19K | $ -46.66K | $ -32.55K |
| EBITDA | $ -128.19K | $ -46.30K | $ -32.55K |
| Net Income | $ -128.19K | $ -46.66K | $ -32.72K |
| Balance Sheet | |||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― |
| Total Assets | $ 641.41K | $ 797.00 | $ 34.13K |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -32.10K | $ -29.00 | $ -27.58K |
| Total Liabilities | $ 255.37K | $ 13.32K | $ 0.00 |
| Stockholders' Equity | $ ― | $ ― | $ ― |
| Cash Flow | |||
| Free Cash Flow | $ -553.71K | $ -27.55K | $ -39.27K |
| Operating Cash Flow | $ -129.03K | $ -26.43K | $ -39.27K |
| Investing Cash Flow | |||
| Financing Cash Flow |
Xeno Transplants Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.